Skip to content

Amerant Bancorp AMTB Cash and Cash Equivalents, at Carrying Value Including Restricted Cash

Cash and Cash Equivalents, at Carrying Value Including Restricted Cash at other companies

Opko Health logo
Opko HealthOPK
$341.88M-21.6%
OFL
Omega FlexOFLX
$49.76M+1.1%
Oaktree Specialty Lending logo
Oaktree Specialty LendingOCSL
$51.26M-52.6%
HRO
HarrowHROW
$94.64M+41.8%
PJT Partners logo
PJT PartnersPJT
$308.78M+58.9%
Bain Capital Specialty Finance logo
Bain Capital Specialty FinanceBCSF
$12.97M+27.6%

Other financials

Income statement

See full
Revenue$97.7M-7.4%
Net income$17.9M+49.5%
EPS (diluted)$0.44+57.1%

Balance sheet

See full
Cash & equivalents$274.2M
Total debt$116.5M+4.9%
Total equity$913.9M+0.8%
Total assets$9.9B-2.6%

Cash flow

See full
Operating cash flow$10.9M-46.0%
CapEx$776.0K-64.9%
Free cash flow$10.1M-43.6%

Valuation

See full
Market cap$978M+40.1%
P/E16.8×
P/S2.3×+0.3×

Profitability

See full
Net margin13.5%
FCF margin28.1%+1.3pp

Returns & leverage

See full
Return on equity6.4%
Debt / equity0.1×0.0×

Where this comes from

Reported directly by Amerant Bancorp in its filing.

Tagged under the XBRL concept amtb:CashAndCashEquivalentsAtCarryingValueIncludingRestrictedCash.

The official record: Amerant Bancorp’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amerant Bancorp's cash and cash equivalents, at carrying value including restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amerant Bancorp's cash and cash equivalents, at carrying value including restricted cash?
Amerant Bancorp (AMTB) reported cash and cash equivalents, at carrying value including restricted cash of $188.71M in Q1 2026.
How has Amerant Bancorp's cash and cash equivalents, at carrying value including restricted cash changed year-over-year?
Amerant Bancorp's cash and cash equivalents, at carrying value including restricted cash decreased by 70.9% year-over-year, from $648.37M to $188.71M.
What is the long-term trend for Amerant Bancorp's cash and cash equivalents, at carrying value including restricted cash?
Over 4 years (2021 to 2025), Amerant Bancorp's cash and cash equivalents, at carrying value including restricted cash has grown at a 14.4% compound annual growth rate (CAGR), from $274.21M to $470.16M.
What does cash and cash equivalents, at carrying value including restricted cash mean?
This metric aggregates total cash and highly liquid short-term investments, including restricted cash balances that are not available for general use. It provides a comprehensive view of the bank's total liquid resources available to support operations or satisfy specific contractual obligations. Investors monitor this to assess the overall liquidity position and potential constraints on capital deployment.